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Abstract
Objectives In Quebec, various actors fund activities aimed
at increasing physical activity, improving eating habits and
reducing smoking. The objective was to evaluate how
effective does the healthy lifestyle habits promotion
(HLHP) strategy need to be to make to offset its costs.
Methods First, we built the logic model of the HLHP
strategy. We then assessed the strategy’s total cost as well
as the direct health care expenditures associated with
lifestyle-related risk factors (smoking, physical inactivity,
insufficient intake of fruits and vegetables, obesity and
overweight). Finally, we estimated the break-even point
beyond which the economic benefits of the HLHP strategy
would outweigh its costs.
Results The HLHP strategy cost for 2010–2011 was esti-
mated at $110 million. Direct healthcare expenditures
associated with lifestyle-related risk factors were estimated
at $4.161 billion. We estimated that 47 % of these
expenditures were attributable to these risk factors.
Conclusions We concluded that the HLHP strategy cost
corresponded to 5.6 % of the annual healthcare expendi-
tures attributable to these risk factors. This study compared
the economic value of HLHP activities against healthcare
expenditures associated with targeted risk factors.
Keywords Economic evaluation  Public health 
Health policy  Burden of disease  Attributable fraction 
Return on investment  Risk factors  Economic benefits 
Healthy lifestyle habits promotion
Introduction
Both the epidemiological landscape and public health
threats have evolved considerably over the past decade in
Western countries, moving from risks of infectious disease
epidemics to a strong prevalence of lifestyle-related health
problems (Brownson et al. 2006). In the United States, for
example, health problems related to lifestyle habits
(smoking, sedentary lifestyle, poor nutrition, excessive
alcohol consumption) account for 900,000 deaths annually,
or nearly 40 % of total mortality (Abraham et al. 2009;
Cohen et al. 2008). Effective public health programs can
increase life expectancy, improve quality of life and reduce
health system costs (Goldsmith et al. 2004). Yet despite the
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available evidence and the recognized health and economic
burdens associated with cardiovascular and respiratory
diseases, diabetes and cancer, public health programs rep-
resent only a very meagre portion of total health spending
(Brownson et al. 2006). Neumann et al. (2008) point out
that even if the value of public health programs appears
obvious in the light of scientific knowledge, the chronic
underfunding of public health activities indicates that
public is not very aware of their value.
In Quebec, various actors fund activities related to
environmental action and education that are aimed at
increasing physical activity, improving eating habits and
reducing smoking (Ministe`re de la Sante´ et des Services
sociaux (MSSS) 2008). The objective of our study was to
evaluate the economic value of such activities in Quebec
which, for purposes of this study, we refer to collectively as
the healthy lifestyle habits promotion (HLHP) strategy. As
the effectiveness of this large scope policy has not been
evaluated, we evaluated how effective does the HLHP
strategy need to be to make to offset its costs. More
specifically, we compared investments to economic bene-
fits, analysing at what point HLHP costs were outweighed
by economic benefits, measured as savings in healthcare
expenditures related to a reduction in risk factors targeted
by HLHP activities. We specifically define the economic
benefits of the HLHP strategy as economic savings in
direct healthcare expenditure (i.e. drugs, hospital care, and
medical care).
In this article, we first describe our methodology, after
which we present the results and discuss the innovative
nature and limitations of this approach. This article may be
of interest to public health authorities and researchers, both
for the information it provides on the economic value of
HLHP activities in Quebec as compared to healthcare
expenditures associated with targeted risk factors, and for
the methodology used to capture information that encom-
passes a broad range of activities and programs, in a
context where actual effectiveness is not known.
Methods
The methodology (Fig. 1) for this study consisted of: (1)
building the logic model for the HLHP strategy and related
activities (Brousselle and Champagne 2011); (2) assessing
the total cost for the HLHP strategy; (3) assessing direct
healthcare expenditures associated with lifestyle-related
risk factors (smoking, physical inactivity, insufficient
intake of fruits and vegetables, obesity and overweight);
and (4) estimating the point at which savings in healthcare
expenditures related to unhealthy lifestyle habits outweigh
HLHP strategy costs (break-even point). In cases of
uncertainty, to obtain a valid and conservative estimate we
overestimated HLHP strategy costs and underestimated
expenditures attributable to complications related to risk
factors.
Our approach has similarities with economic evaluation
and program evaluation methods: logic model (Brousselle
and Champagne 2011), cost-benefit (Commonwealth
Department of Health and Ageing 2003; Drummond et al.
2005), cost-offset type studies (Chiles et al. 1999; Kelly
et al. 2005), and cost-consequence analysis (Canadian
Agency for Drugs and Technologies in Health (CADTH)
2006; Coast 2004). The methods used in this economic
evaluation are, to some extent, similar to those used in the
previous studies assessing the economic impact of chronic
diseases in other Canadian provinces or other countries
(Conference Board of Canada 2010; Katzmarzyk and
Janssen 2004; Krueger et al. 2013; Scarborough et al.
2011), and the economic benefits of a water fluoridation
program (Tchouaket et al. 2013).
HLHP strategy logic model development
The logic model provides an exhaustive representation of
the resources, activities (programs, interventions), expected
effects, and impacts associated with those effects (Drum-
mond et al. 2005; Funnell and Rogers 2011). To build this
logic model, we consulted the grey and the scientific lit-
eratures. The model underwent two rounds of validation by
public health experts and people closely involved in the
strategy’s design and coordination.
Assessing the total cost of Quebec’s HLHP strategy
The strategy we evaluated is made up of many programs
and activities funded by various actors at the federal,
provincial, regional, and community levels. As such, to
identify all the activities aimed at promoting healthy life-
style habits and quantify how much is allocated to each
activity would present a very complex challenge. We were
able to get around this problem by identifying primary
sources of funding and evaluating the total amounts gran-
ted by each of them annually.
To identify the primary funders and the amounts
invested, we consulted the grey literature (financial reports
of organizations, government reports) and people involved
in public health administration. A top down costing
approach was selected to estimate the cost of the HLHP
strategy. We used the standardized costs of the Programme
national de sante´ publique–PNSP (Quebec Public Health
Program), which are primary estimates of the human
resources needed at local and regional levels to plan,
implement, and coordinate public health activities (Direc-
tion ge´ne´rale de la sante´ publique–DGSP 2010). These data
are estimates that are likely higher than what is actually
4 T. Benmarhnia et al.
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invested in public health in Quebec, making them conser-
vative estimates for determining the break-even point. We
used 2010–2011 fiscal year costs for the analyses. The data
on the costs of prevention activities were validated by
experts working for Quebec’s Ministry of Health and
Social Services (MSSS).
Assessing direct healthcare expenditures associated
with lifestyle-related risk factors
Cost of diseases associated with unhealthy habits
in Quebec
The first step in assessing healthcare expenditures
attributable to modifiable risk factors is to calculate the
costs of chronic diseases associated with those factors. As
illustrated in the logic model, the diagnoses retained for
calculating disease costs were those shown in the literature
to be associated with the risk factors targeted by the HLHP
strategy (smoking, insufficient intake of fruits and veg-
etables, physical inactivity, obesity and overweight). We
did not include in our calculations all the healthcare
expenditures attributable to these risk factors, but rather the
principal ones, such that the calculated level of effective-
ness at which economic benefits surpass HLHP strategy
costs is a conservative estimate (higher than what it would
be in reality). It should be noted that, in our study, we
excluded from the calculation of costs attributable to risk
factors: (1) indirect costs (e.g. mortality, lost productivity);
(2) costs related to other illnesses associated with the risk
factors (e.g. vascular disease related to diabetes, some
types of cancers); and (3) other nonmedical outcomes such
as improved quality of life and higher self-esteem. Hence,
by not quantifying the indirect costs, we considerably
underestimated the costs attributable to risk factors.
Using data from the Economic Burden of Illness in
Canada (EBIC) studies (Public Health Agency of Canada
(PHAC) 2000), we calculated the direct costs of these
chronic diseases in Quebec in 2010 for hospitalizations,
ambulatory care visits, and medications. This is the same
source of data on illness costs that has been used in other
studies to determine the costs of some chronic diseases in
Canada (Conference Board of Canada 2010; Krueger et al.
2013; Katzmarzyk and Janssen 2004). The data in the
EBIC report on the costs of illnesses are the result of
complex analyses performed over more than 10 years by
the Public Health Agency of Canada (PHAC) on data from
several Canadian Institute for Health Information (CIHI)
databanks and from self-reported surveys, including the
Canadian Community Health Survey (CCHS) (Health
Canada 2002). To calculate the costs of illness in 2010, we
extrapolated the cost data from 2000 over an 11-year span
using CIHI’s National Health Expenditure Database (CIHI
2012). In this way, we obtained a projection of the annual
costs of illness in relation to changes in spending in dif-
ferent sectors of health-related activity (e.g. medications,
hospitalizations, medical visits).
Assessing the proportion of the costs
attributable to the risk factors
Using cost data attributable to specific effects (medications,
hospitalizations, medical visits), we calculated the number of
cases of illness attributable to the risk factors under consid-
eration (smoking, insufficient intake of fruits and vegetables,
physical inactivity). For this, we calculated the proportions
attributable to each risk factor for all the illnesses.
Many epidemiologic studies have assessed the link
between lifestyle habits or changes (such as smoking ces-
sation) and chronic disease incidence. In this study, we
considered various exposures and health effects. Based on
the relationships expressed between a given exposure and a
corresponding effect—for example, with relative risks
(RR)—and using the prevalence of this exposure, it is
Building the logic 
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Assessing the total cost of the 
HLHP in Quebec
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Fig. 1 Methodological process.
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possible to calculate a population attributable fraction
(PAF) using the formula 1.
PAF ¼ Pe ðRR  1Þ=Pe ðRR  1Þ þ 1 ð1Þ
where Pe represents the exposure prevalence (in a given
context) and RR the relative risk, expressing the relation-
ship between exposure and effect.
PAFs were calculated separately for each exposure/
health effect relationship (RR) considered in this study.
From each PAF it was then possible to calculate a number
of cases attributable to one exposure or, in this situation,
the proportion of disease costs attributable to the risk fac-
tor. We calculated adjusted PAFs following the approach
described in studies by Benichou (2001), Hanley (2001),
and Steenland and Armstrong (2006) to consider the level
of exposure for a given risk factor (e.g. smokers, occasional
smokers, former smokers, and never smokers) and multi-
exposure for one given health effect (e.g. the combined
impact of smoking and physical inactivity and obesity).
PAF estimates were adjusted for level of exposure when
data was available (e.g. smoker, occasional smoker, former
smoker, never smoker). By doing this dual adjustment, we
avoided double-counting the economic burden of the risk
factors (Krueger et al. 2013). To calculate the number of
cases (for the health effects considered) and the proportion
of costs attributable to each exposure, we undertook a
multi-stage process of systematic review and data analysis,
details of which are presented in the supplemental material.
Evaluating the point at which savings in healthcare
expenditures outweigh the costs of the HLHP strategy
We then estimated the point at which savings in healthcare
expenditures related to unhealthy lifestyle habits out-
weighed HLHP strategy costs. To estimate this break-even
point (%), we used formula 2:
Total amount allocated to HLHP strategy ð$Þ
Direct health expenditures attributable to targeted risk factors ð$Þ
ð2Þ
The break-even threshold represents the minimal level
of savings required to offset the cost of the HLHP strategy;
in fact, the real threshold is most certainly below the
calculated threshold, since we did not include in our
calculations all the costs attributable to risk factors.
Discounting
To take into account the fact that effects occur several years
after investments in prevention activities, we modelled the
occurrence of effects on different time horizons (0, 5, 10, 15
and 20 years) by discounting the costs attributable to the risk
factors using discount rates recommended by the Center for
Public Health Excellence at National Institute for Health and
Clinical Excellence (NICE 2011) (1.5 % for health benefits
and 3.5 % for costs) and using Canadian Institute for Health
Information (Canadian Institute for Health Information
(CIHI) 2012) data on health expenditures in Canada to pro-
ject the increases in healthcare expenditures attributable to
these illnesses. Between 2000 and 2010, health expenditures
(in 1997 constant dollars) increased by 4.4 % annually. We
assumed costs attributable to the risk factors would increase
at the same rate (4.4 %) as health expenditures in Canada
over recent years. Different sensitivity analyses were con-
ducted that are presented in the supplemental material.
Results
The logic model
Given the scope and complexity of the HLHP strategy, the
logic model was divided into two different models: one
presenting the resources, activities, and key effects
(Fig. 2); and another depicting the chain of effects of
adopting healthy lifestyle habits (Figure S1). It is important
to recall that these models were built with the idea that only
health expenditures avoided due to reduction in chronic
illnesses (direct costs of risk factors) would be estimated
for the economic analysis.
Cost of the HLHP strategy
Healthy lifestyle habits promotion and chronic disease pre-
vention activities were grouped into five categories based on
type of funding. For each category, Table S2 presents all the
subcategories of activities, their funding sources, examples
of interventions, and their costs for the year 2010–2011.
Total cost was estimated at approximately $110 million for
the 2010–2011 fiscal year (amounts given in this paper are in
Canadian dollars). As presented in Table S2, some costs could
not be quantified for some sources of funding. These costs
seem to be negligible compared to the main sources of fund-
ing. Furthermore, certain costs may be overestimated; in
particular the PNSP’s standardized costs. For the sensitivity
analyses, we assumed the costs of the HLHP strategy could
vary between $90 million and $150 million.
Direct healthcare expenditures associated with lifestyle-
related risk factors
Cost of diseases associated with unhealthy habits
in Quebec
The total direct healthcare expenditures of chronic diseases
selected for our study in Quebec in 2010 are presented in
6 T. Benmarhnia et al.
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Table 1. Using the health expenditure data from CIHI and
data from the EBIC survey, we estimated the total all-cause
direct healthcare expenditures to be $21.72 billion in 2010
in Quebec—and more specifically, as related to the dis-
eases targeted in our study, $379 million for diabetes
mellitus, $3.45 billion for cardiovascular diseases, over
Fig. 2 Logic model of the healthy lifestyle habits promotion strategy in Quebec. Canada 2016
Table 1 Economic burden of illness by diagnostic category in Quebec
Code Cause Direct costs*, 
Drugs Hospital care Medical care All direct costs
W000 All causes $6,267,268,479 $10,801,577,118 $4,647,884,743 $21,716,730,340
W060 A. Malignant tumours
W064 4. Colon and rectal cancer $3,682,912 $112,028,852 $16,223,691 $131,935,455
W067 7. Tracheal, bronchial and lung cancer $4,750,870 $123,715,726 $23,135,123 $151,601,720
W069 9. Breast cancer $13,768,738 $42,144,588 $21,509,603 $77,422,929
W079 C. Type 2 diabetes $147,840,004 $132,547,663 $99,296,278 $379,683,944
W104 G. Cardiovascular diseases
W106 2. Hypertensive disease $741,822,143 $57,843,016 $169,159,096 $968,824,255
W107 3. Ischemic heart disease $290,308,382 $505,568,277 $167,814,583 $963,691,242
W108 4. Cerebrovascular disease $22,588,070 $396,509,597 $38,292,634 $457,390,301
W111 H. Respiratory conditions
W112 1. Chronic obstructive pulmonary disease $83,672,505 $229,684,077 $81,379,783 $394,736,365
W113 2. Asthma $206,389,146 $69,830,400 $59,673,740 $335,893,285
W125 L. Musculoskeletal diseases
W127 2. Osteoarthritis (arthrosis) $57,525,894 $138,020,356 $43,047,497 $238,593,747
Canada 2016
* Forecasts based on health expenditure data from Canadian Institute for Health Information (CIHI) and Economic Burden of Illness in Canada
(EBIC) data from the Public Health Agency of Canada (Katzmarzyk and Janssen 2004; Kelly et al. 2005; Krueger et al. 2013).
 The chronic diseases selected in our economic model (subcategories A4, A7, A9, C, G2, G3, G4, H1, H2, L2) were responsible for
$4.161 billion of direct healthcare spending in 2010
Investing in a healthy lifestyle strategy: is it worth it? 7
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$700 million for asthma and chronic obstructive pul-
monary diseases (COPD), and over $360 million for lung,
colorectal, and breast cancers. Based on our forecasts, the
chronic diseases selected in our economic model (subcat-
egories presented in Table 1) were responsible for
$4.161 billion of direct healthcare spending in 2010.
Therefore, chronic diseases related to modifiable risk fac-
tors were responsible for an important part (approximately
one fifth) of total direct healthcare expenditures in 2010 in
Quebec.
Assessing the proportion of the costs
attributable to the risk factors
The studies included in our literature review and the
selected RRs for each risk factor are presented in Table S1.
Relative risks, the prevalence of exposure, and the PAFs of
total chronic disease costs for each risk factor and each
chronic disease are presented in Table 2. According to the
CCHS survey, the prevalence of smoking among persons
aged 12 years and older in Quebec was 18.9 % among
males and 15.7 % among females in 2009–2010. In that
same year, 56.7 % of men and 39.7 % of women had
insufficient intake of fruits and vegetables (fewer than five
portions daily), and 58.2 % of men and 63.5 % of women
did not reach the recommended level of physical activity.
The prevalence of obesity and overweight were 17.5 and
41.0 %, respectively, in men and 15.4 and 27.1 % in
women (Table 2).
Table 2 presents PAF estimates adjusted for multiple
exposures to each disease (combined effect of having
multiple risk factors for the same disease); the crude esti-
mates of costs associated with each risk factor, and the
adjusted costs associated with these risk factors for specific
diseases assessed using the adjusted PAF estimates
(Table 3). The targeted risk factors were responsible for
over $1 billion of cardiovascular disease costs (respec-
tively, $522, $436, and $161 million for ischemic heart
diseases, hypertension, and stroke) in Quebec in 2010. In
addition, they were also responsible for most of the direct
healthcare expenditures for COPD ($222 million), lung
cancer ($111 million), and diabetes mellitus ($259 mil-
lion). Looking specifically at each risk factor, smoking,
obesity and overweight, insufficient intake of fruits and
vegetables, and physical inactivity were responsible for
$699 million, $951 million, $403 million, and $232 mil-
lion in direct healthcare expenditures, respectively, in
2012.
After adjusting for multiple exposures, the sum of all
direct healthcare expenditures attributable to the selected
risk factors was estimated at $1.958 billion in 2010, cor-
responding to nearly half the total expenditures for related
chronic diseases ($4.16 billion). In fact, these risk factors
were responsible for 47 % of all direct healthcare expen-
ditures associated with the chronic diseases included in our
study.
The point at which healthcare expenditure savings
outweigh HLHP strategy costs
Using the baseline estimate of the costs of the HLHP strategy
($110 million), we estimated that the costs of HLHP activ-
ities in Quebec represented 5.62 % of the total healthcare
expenditures attributable to the risk factors ($1.958 billion).
This estimate does not include these diseases’ indirect costs,
such as the economic impact of mortality and lost produc-
tivity due to long-term and short-term disabilities, nor the
direct costs of other diseases associated with unhealthy
lifestyle choices. Hence, the real break-even point is likely to
be lower than the estimate we calculated.
Discounting the effects
Table S3 presents the results of the analyses of the impact
of discounting the effects (3.5 % discount rate) and
accounting for increases in healthcare spending over dif-
ferent time horizons. If the economic benefits (savings
from disease avoidance) are assumed to occur 10, 15, or
20 years after the HLHP activities, the break-even point
decreases to 5.15, 4.93, and 4.72 %, respectively.
Discussion
Quebec’s HLHP strategy is a large-scale program encom-
passing all activities related to environmental actions and
education that are aimed at increasing physical activity,
improving eating habits, and reducing tobacco use (Min-
iste`re de la Sante´ et des Services sociaux (MSSS 2008).
The costs of these activities were estimated at $110 million
in 2010. Very few studies have comprehensively estimated
the total cost of health promotion activities. One other
study that attempted to quantify the costs of such activities
in Quebec produced a higher estimate of $127 million in
2008 ($31 million for smoking cessation programs and
$96.3 million for obesity prevention activities) (Manuel
et al. 2009). In addition, the objective of this paper was to
assess how effective does Quebec’s HLHP strategy need to
be to make to offset its costs. This analysis goes beyond a
separated calculation of the two sides of the costs. By
estimating the point at which healthcare expenditure sav-
ings outweigh HLHP strategy costs (5.62 %), we were thus
able to highlight the potential amplitude of further public
health investments.
In this study, healthcare expenditures attributable to the
risk factors targeted by the HLHP strategy were estimated
8 T. Benmarhnia et al.
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Table 2 Assessment of Population attributable fractions (PAF) of total direct healthcare costs
Chronic diseases Risk factors (RF) Men Women
RRa (95 % CIb) Pc (%) Adj.
PAFd (%)
RRa (95 % CIb) Pc (%) Adj.
PAFd (%)
(1) Pulmonary diseases
Chronic obstructive
pulmonary disease
Smoker 4.11 3.28 5.15 18.9 59.9 3.28 2.35 4.58 15.7 39.4
Occasional smoker 2.14 1.87 2.46 6.3 2.14 1.87 2.46 4.9
Former smoker 2.97 2.63 3.34 42.3 1.61 1.46 1.77 38.8
Insufficient consumption of
fruits and vegetables
1.32 1.09 1.67 56.7 15.2 1.32 1.09 1.67 39.7 11.1
Asthma Smoker 1.70 1.30 2.20 18.9 13.6 1.30 0.80 2.30 15.7 6.3
Occasional smoker 1.40 1.20 1.60 6.3 1.40 1.20 1.60 4.9
Obesity 1.43 1.14 1.79 17.5 13.6 1.78 1.36 2.32 15.4 15.8
Overweight 1.20 1.08 1.33 41.0 1.25 1.05 1.49 27.1
(2) Cancers
Lung cancer Smoker 8.96 6.63 12.1 18.9 73.0 7.58 5.36 10.7 15.7 68.1
Former smoker 3.85 2.77 5.34 42.3 3.85 2.77 5.34 38.8
Insufficient consumption of
fruits and vegetables
1.21 1.04 1.45 56.7 10.6 1.21 1.04 1.45 39.7 7.7
Breast cancer Physical inactivity 1.49 1.00 2.27 63.5 23.7
Insufficient consumption of
fruits and vegetables
1.12 1.01 1.25 39.7 4.5
Post-menopausal
breast cancer
Obesity 1.15 1.08 1.23 15.4 4.3
Overweight 1.08 1.03 1.23 27.1
Colon and rectum
cancer
Obesity 1.95 1.59 2.39 17.5 27.3 1.66 1.52 1.81 15.4 18.3
Overweight 1.51 1.37 1.67 41.0 1.45 1.30 1.62 27.1
Physical inactivity 1.26 1.10 1.47 58.2 13.1 1.40 1.13 1.74 63.5 20.3
(3) Cardiovascular
diseases
Stroke Obesity 1.26 1.07 1.48 17.5 6.2 1.26 1.07 1.48 15.4 5.1
Overweight 1.05 0.93 1.17 41.0 1.05 0.93 1.17 27.1
Insufficient consumption of
fruits and vegetables
1.20 1.12 1.30 56.7 10.4 1.05 0.96 1.14 39.7 2.0
Physical inactivity 1.25 1.15 1.35 58.2 12.7 1.22 1.14 1.32 63.5 12.3
Smoker 1.43 1.35 1.52 25.2 15.3 1.72 1.59 1.86 20.6 17.6
Former smoker 1.17 1.05 1.88 42.3 1.17 1.05 1.88 38.8
Ischemic heart
diseases
Obesity 1.72 1.51 2.24 17.5 19.7 3.10 2.81 3.43 15.4 35.1
Overweight 1.29 1.18 1.41 41.0 1.80 1.64 1.98 27.1
Insufficient consumption of
fruits and vegetables
1.11 1.02 1.22 56.7 5.9 1.32 0.95 1.82 39.7 11.1
Physical inactivity 1.10 0.96 1.30 58.2 5.5 1.25 1.09 1.45 63.5 13.7
Smoker 1.60 1.26 2.02 25.2 12.8 3.22 2.47 4.22 20.6 34.0
Former smoker 0.99 0.69 1.42 42.3 1.15 0.92 1.44 38.8
Hypertension Obesity 1.84 1.51 2.24 17.5 20.7 2.42 1.59 3.67 15.4 28.3
Overweight 1.28 1.10 1.50 41.0 1.65 1.24 2.19 27.1
Physical inactivity 1.47 1.11 2.70 58.2 21.5 1.47 1.11 2.70 63.5 23.0
Smoker 1.15 1.03 1.27 25.2 6.7 1.15 1.03 1.27 20.6 5.8
Former smoker 1.08 1.01 1.15 42.3 1.08 1.01 1.15 38.8
(4) Metabolic diseases
Type II diabetes Obesity 6.48 5.17 8.13 17.5 61.9 8.38 5.46 12.85 15.4 65.1
Overweight 2.63 2.09 3.32 41.0 3.69 2.52 5.40 27.1
Insufficient consumption of
fruits and vegetables
1.20 1.11 1.32 58.2 10.4 1.20 1.11 1.32 63.5 11.3
Physical inactivity 1.04 0.85 1.27 56.7 2.2 1.04 0.85 1.27 39.7 1.6
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at $1.958 billion in 2010. As such, the cost of the HLHP
strategy ($110 million) represents only 5.6 % of the
healthcare expenditures associated with these risk factors.
In another study conducted in Manitoba, Krueger et al.
(2013) estimated the direct costs attributable to the same
risk factors as considered in our study to be $490 million in
2008, substantially lower than our estimate. However,
when adjusted for the number of inhabitants per province,
the costs associated with these risk factors in the Manitoba
study ($409 per capita; total population of 1,197,774 in
Manitoba in 2008) are higher than our estimates ($247 per
capita; total population of 7,923,365 in Quebec) (Statistics
Canada 2014). This difference may be explained by a
different study design and different risk factors retained for
the assessment of total healthcare expenditures. In the
study by Krueger et al. (2013), the indirect costs of these
risk factors, notably the costs of lost productivity, long-
term disability, and mortality—which were not included in
our study—represented 70 % of total costs ($1.114 billion
out of a total $1.6 billion). This highlights the magnitude of
the indirect costs associated with these risk factors in
Canada. In our study, if the indirect costs associated with
these risk factors represented 70 % of the total costs, the
total costs would be $6.53 billion.
Challenges
Several challenges emerged during this evaluation
(Drummond et al. 2008; Shiell et al. 2008; Weatherly et al.
2009). First, a health promotion strategy is not a single,
confined intervention; it is in fact a number of actions,
interventions, and programs with a common orientation,
each with its own costs and funding, and leading to
widespread and long-term effects with complex causalities
(Craig et al. 2008). Developing a complete and accurate
description of all activities related to the HLHP strategy as
well as their sources of funding represented a challenge in
itself. Nevertheless, the fact that the HLHP strategy
included all activities related to healthy habits, allowed us
to work with attributable risks for estimating the potential
healthcare cost savings at the provincial level.
Second, the element of time is likely to influence these
results (Soler et al. 2016), although it is difficult to foresee
in what way. First, illness-related costs will be avoided
over a certain number of years, but it is impossible to
estimate this time horizon with any precision. We per-
formed sensitivity analyses assuming avoided
expenditures at time horizons of 5, 10, 15, and 20 years
by discounting, with various discount rates,
attributable costs and adjusting for expenditure increases
over time. The results of these analyses indicated that
taking into account the time horizon has a limited impact,
as the discount rates are similar to the annual rates of
increases in health expenditures in Canada (4.4 %). Such
analyses also run into certain methodological limitations,
such as the difficulty of forecasting time horizons for
effects and of anticipating changes in disease manage-
ment approaches. These methodological limitations may
influence, in either direction, the costs of treatment and
future savings generated by the HLHP strategy. More-
over, identifying activity costs is a challenge when
dealing with a strategy encompassing many activities.
Some costs may not have been listed and others may have
been overestimated or underestimated. To counteract this
limitation, we used high estimates of activity costs in
modelling to be sure of obtaining conservative results. We
also performed sensitivity analyses to assess the impacts
of program and activity cost variations on our results.
Strengths
To estimate the portion attributable to each risk factor, we
used measures of association drawn from a literature
review (See Table S1 in Supplemental material), with strict
Table 2 continued
Chronic diseases Risk factors (RF) Men Women
RRa (95 % CIb) Pc (%) Adj.
PAFd (%)
RRa (95 % CIb) Pc (%) Adj.
PAFd (%)
(5) Musculoskeletal
diseases
Osteoarthritis Obesity 4.20 2.76 6.41 17.5 56.2 1.96 1.88 2.04 15.4 26.7
Overweight 2.76 2.05 3.70 41.0 1.80 1.75 1.85 27.1
Canada 2016
a Relative risk
b Confidence interval
c Prevalence
d Population attributable fraction
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selection criteria that would most closely approximate the
characteristics of the population of Quebec. This approach
meant that the selected measures of association could not
be directly attributed to the study population. Nevertheless,
to limit this bias and to estimate the proportions that could
be attributable, we developed an approach that allowed for
Table 3 Direct healthcare costs associated to lifestyle-related risk factors
Chronic diseases Direct healthcare
costs (CAN $2010)
Risk factors (RF) Adj. PAFa
(%)
Costs attributable to
risk factors ($)
Total costs adjusted
for multiple
exposition ($)
(1) Pulmonary diseases
Chronic Obstructive
Pulmonary disease
$394,736,365 Smoking 49.52 $195,464,225 $221,658,019
Insufficient consumption of
fruits and vegetables
13.14 $51,887,048
Asthma $335,893,285 Smoking 9.88 $33,195,061 $77,751,443
Obesity and overweight 14.72 $49,442,607
(2) Cancers
Lung cancers $151,601,720 Smoking 70.56 $106,973,175 $111,056,160
Insufficient consumption of
fruits and vegetables
9.15 $13,869,767
Breast cancers $77,422,929 Physical inactivity 4.55 $3,520,702 $21,058,496
Insufficient consumption of
fruits and vegetables
23.73 $18,373,294
Post-menopausal
breast cancers
$61,164,114 Obesity and overweight 4.29 $2,621,537 $2,621,537
Colon and rectum
cancers
$131,935,455 Obesity and overweight 22.71 $29,963,004 $47,049,393
Physical inactivity 16.76 $22,106,957
(3) Cardiovascular
diseases
Stroke $457,390,301 Smoking 16.48 $75,356,930 $161,321,080
Insufficient consumption of
fruits and vegetables
6.17 $28,230,351
Physical inactivity 12.48 $57,064,937
Obesity and overweight 5.63 $25,751,457
Ischemic heart diseases $963,691,242 Smoking 23.55 $226,961,558 $522,497,040
Insufficient consumption of
fruits and vegetables
8.57 $82,558,945
Physical inactivity 9.67 $93,144,537
Obesity and overweight 27.50 $264,972,860
Hypertension $968,824,255 Smoking 6.25 $60,584,638 $436,253,706
Insufficient consumption of
fruits and vegetables
22.24 $215,504,459
Obesity and overweight 24.59 $238,211,364
(4) Metabolic disease
Type II diabetes $379,683,944 Insufficient consumption of
fruits and vegetables
1.89 $7,161,712 $258,622,744
Physical inactivity 10.85 $41,212,151
Obesity and overweight 63.55 $241,271,621
(5) Musculoskeletal diseases
Osteoarthritis $238,593,747 Obesity and overweight 41.21 $98,326,933 $98,326,933
Direct costs of chronic
diseases
$4,160,937,358 Total costs
attributable to risk
factors
$1,958,216,550
Canada 2016
a Population attributable fraction
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systematic selection of measures of association and incor-
porated a sensitivity analysis. This approach can be
replicated in other contexts and makes it possible, using
criteria from the studies identified in the literature review,
to prioritize RRs in ways that will ensure the study popu-
lation is represented as accurately as possible.
The originality of our study is that it compares invest-
ments in health promotion activities against amounts
devoted to treating major diseases associated with the tar-
geted risk factors. We have no effectiveness data, but we
believe that achieving the healthy lifestyle objectives set by
the MSSS would result in considerable savings that would
completely finance the HLHP strategy. Although it is dif-
ficult to change people’s lifestyle habits, efforts over recent
years to reduce smoking in Quebec have lowered smoking
prevalence from 27 % in 2003 to 24 % in 2009–10 (DGSP
2012). In comparison with the burden that lifestyle habits
related diseases will represent in coming years according to
current epidemiological trends, investments in HLHP
activities seem relatively small (Poirier and Jobin 2011).
Our results indicate as it is likely that even a small effec-
tiveness in risk reduction could produce important savings
for the healthcare system in terms of costs averted.
Conclusion
Lifestyle-related illnesses have become a major public
health concern around the world over recent years, and the
growing prevalence all around the world is a serious con-
cern for public health authorities (Geneau et al. 2010). In
this article, we show that it is possible to conduct an eco-
nomic evaluation of a large-scale health promotion strategy
encompassing multiple interventions, activities, and pro-
grams. The methodology we used is situated at the
intersection of several fields. We combined methods from
the fields of evaluation, economic evaluation, and epi-
demiology. We were able to assess the economic value of
the HPHL strategy by comparing its costs to the healthcare
expenditures associated with diseases related to targeted
risk factors.
Our study demonstrates that the financial risk of
investing in health promotion activities aimed at improving
lifestyle habits is small when compared with the financial
burden of diseases associated with the targeted risk factors.
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